课题基金 / 基金详情

BORTEZOMIB AND PEGYLATED LIPOSOMAL DOXORUBICIN AS THERAPY FOR MULTIPLE MYELOMA

BORTEZOMIB AND PEGYLATED LIPOSOMAL DOXORUBICIN AS THERAPY FOR MULTIPLE MYELOMA
硼替佐米和聚乙二醇化脂质体阿霉素治疗多发性骨髓瘤
批准号：
7377543
负责人：
ROBERT ZYGMUNT ORLOWSKI
金额：
$2.23万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
项目状态：
已结题
起止时间：
2005-12-01 至 2006-11-30
来源：
https://reporter.nih.gov/project-details/7377543
关键词：
BORTEZOMIBPEGYLATEDLIPOSOMALDOXORUBICINTHERAPY

项目摘要

项目成果

ROBERT ZYGMUNT ORLOWSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to find out what effects (good and bad) the drugs Bortezomib and pegylated liposomal doxorubicin have on multiple myeloma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteasome Assembly Chaperones in Sensitivity and Resistance to Proteasome Inhibitors
Proteasome Assembly Chaperones in Sensitivity and Resistance to Proteasome Inhibitors
P3 - TARGETING THE HDM-2 E3 LIGASE IN MULTIPLE MYELOMA
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
海外基金